Deaconess News Room > Deaconess Update and FAQs on Fungal Meningitis
Latest newsRSS

Deaconess Update and FAQs on Fungal Meningitis

10/4/2012
The CDC has identified an injectable steroid medication product from one drug deaconess health alertmanufacturer as the likely source of a fungal meningitis outbreak affecting five southeastern states, including Indiana. A common use of this drug is epidural steroid injections, a procedure used to treat back pain.

The CDC reports that this fungal meningitis outbreak is associated with injections beginning July 1, 2012.  The outbreak is not contagious from person-to-person.  Typical symptoms of meningitis include headache, stiff neck, fever, sensitivity to light and altered mental status.  These symptoms may begin between 2 days and 28 days after the injection.

Patients who exhibit the above symptoms need to report to the nearest emergency department.

Deaconess Health System is prepared to care for patients who are exhibiting the signs and symptoms of meningitis.  If the recall is expanded, the public will be informed.

For a list of FAQs on this outbreak, visit deaconess.com/healthalert >>